Correction: Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin
Year: 2026
Type: erratum
Abstract: Correction on: Qian J, Cheng W, Li S, Deng L, Gao D, Zhang X and Zhang Y (2026) Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin. Front. Pharmacol. 16:1727729. doi: 10.3389/fphar.2025.1727729 Wrong content There was a mistake in figure [Figure 2F,2G; Figure 3D (bar graph for cell lines H358 and H1299); Figure6 A, 6D] as published. The compound name "Rhoifolin" was incorrectly spelled as "Phoifolin". There was a mistake in figure [Figure 2B] as published. The legend label for the "48 h" time point was incorrectly written as "48 4" . There was a mistake in figure [Figure 3D ] as published. The asterisks indicating statistical significance on the bar graph were omitted. The corrected Figure 2,Figure 3 and Figure 6 appears below. The original version of this article has been updated.Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.
Source: Frontiers in Pharmacology
Authors: Jing Qian, Wei Cheng, Shuangyan Li, Li Deng, Di Gao, Xue Zhang, Yunhui Zhang
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7128718659
Cites:
Cited by:
Related to: